Unique source of Omega 3 oil with a high percentage of Eicosapentaenoic acid. This EPA is linked to polar lipids (phospholipids and glycolipids) improving their digestibility and health benefits in comparison with other Omega 3 sources present in the market.
The unique natural source of Omega 3 EPA obtained from sustainable and autotrophic microorganisms in an industrial scale that guarantee a continued production and quality on a large scale all the time.
Not only a source of Omega 3 NaturEPA also contains Antioxidants such as Vitamin E (α-tocopherol), Hidroxitirosol and Pigments such as β-Carotene that help to protect the body's cells from free radical damage and Natural Phytosterols which reduce Cholesterol and indirectly help to prevent Cardiovascular Diseases.
NaturEPA also contains Antioxidants such as Vitamin E (α-tocopherol), Hidroxitirosol and Pigments such as β-Carotene that help to protect the body's cells from free radical damage and Natural Phytosterols which reduce Cholesterol and indirectly help to prevent Cardiovascular Diseases.
|High Bio-availability||Best absorption of Omega 3, because it is linked to phospholipids and glycolipids improving their digestibility|
|Antioxidant Protection||Contains naturally Vitamin E (α-tocopherol), Hidroxitirosol and Corotenoids such as β-Carotene that help to protect the body's cells from free radical damage. And natural Phytosterols which reduce cholesterol and indirectly help to prevent cardiovascular disease|
|Healthy||Omega 3 EPA helps with cardiovascular function, nervous system functions, immunity and neurotransmission|
|For Vegans||Vegetable origin that can be consumed by vegans and vegetarians in contrast to other Omega 3 oils availabe in the market||Sustainability||The environmental sustainability of our process is guaranteed in contrast to other Omega 3 sources||Eco friendly process||Marine phytoplankton needs CO2 and the energy of the sun light to grow and reproduce by mitosis|
The lipid fraction has a high Content of Omega 3 Fatty Acids (EPA), of a high quality, eicosapentaenoic acid compound conjugated with polar lipids (phospholipids and glycolipids) providing EPA health benefits with easy digestibility.
• Mainly composed by polar lipids (phospholipids and glycolipids)
• Contains not less than 35% of eicosapentaenoic acid (EPA), omega 3 and most EPA (w-3) is bound to polar lipids.
• No additive is added. This product is stabilized by natural presence of natural antioxidants and natural α-tocopherol.
Concentration of Omega 3 (regarding total fatty acids): Analyzed by CG-FID (Internal method).
– Total Omega 3 (as Free Fatty Acids) 43.8 %
– EPA, Eicosapentaenoic acid (as Free Fatty Acids) 39.5 %
|FATTY ACIDS||% (w/w)*|
|C18:3 3 ALA||0,4|
|C20:4 6 ARA||3,9|
|C20:5 3 EPA||39,5|
• NATURAL TOCOPHEROLS: ≤ 150 mg/100g (HPLC, Internal method)
• PHYTOSTEROLS(beta-Sitosterol, Estigmnasterol, Campesterol,…): > 830 mg/100 g
• BIOPHENOLS(Hidroxitirosol and Hidroxitirosol acetate): >190 mg/100 g
• SAPONIFIABLE LIPID SPECIES:(percentage of total saponifiable lipids)
|Polar lipids (PL) 88,9%||Triacylglyceride (TAG) 5,2%|
|Monoacylglyceride (MAG) 1,2%||Free fatty acid (FFA) 0,0%|
|Diacylglyceride (DAG) 4,8%||Sterol ester (CE) 0,0%|
• Cardiovascular Disease (CVD): The World Health Organization has recognized connections between Omega 3 and decreased risks of CVD. EPA is good for the heart's health
• Atherosclerosis: Omega 3 Polyunsaturated Fatty Acids such as EPA and Phytosterols can modulate the mechanisms of development and progression of atherosclerosis and helps control the cholesterol levels
• Anti-inflammatory effect: Because of its capacity to reduce inflammation, EPA protects against illnesses related to an inflammatory etiology such us: diabetes, heart disease, and metabolic syndrome
• More benefits: Omega 3 improves the immunological system. the reproductive system, skin, moods and others.
According to the Global Organization for EPA and DHA Omega 3s (GOED), the ocean can not provide enough Omega 3, EPA and DHA, to fulfill market demand. This presents a real versfishing problem for many marine species.This means that other sources are required to close the broader gap and relieve pressure on fisheries.
Recently several farm-grown algae announce the algae production to obtain Omega 3 oil as alternative as fish and krill oil. But the current algae production is in open ponds with the limitations that this entails: low yield, limited production, higher risk of contamination, large evaporation (100 m3/day/hectare), large cultivation area, poor light utilization and less yield of CO2 absorption.
BASM Blue technology uses vertical, closed bio-reactors with a specific shape that fully automatizes the production process in an aseptic atmosphere, maintaining high quality and homogeneous products throughout the year. This means a controlled environment for best growth conditions that guarantee good production and quality on a large scale all the time.
Marine animals, specifically fish and krill, currently represent the main sources for nutritional Omega 3 supplements. Fish oil is the major source for natural (triglyceride) and processed (ethyl-ester) forms of Omega 3 fatty acids (EPA and DHA). Recently, concerns have been raised regarding the sustainability of global fish populations, as pollution and over-harvesting have led to a constant decline in fish population world-wide. In addition, fish oil faces potential contamination as a result of environmental contaminants consumed by the fish.
Krill oil is currently the major source for high bioavailability polar-lipid Omega 3 oil and is extracted from a specific species of krill, Euphausia superba (Antarctic krill). Krill is considered by many scientists to play a key role in the marine Antarctic ecosystem, serving as the main food source for animals such as penguins, seals and whales as well as sea-birds and fish.
NaturEPA does not in any way deplete marine animal population or threaten the delicate eco-balance in our oceans.
One of the advantages of our Omega 3 is that, it is a rich oil with a high EPA content opposed to the DHA ratio present in other oils rich in Omega 3 on the market. Most researchers have attributed beneficial effects to the ω-3 fatty acids but the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are not differentiated in most studies. Although EPA and DHA are both long chain polyunsaturated fatty acids (EPA, C20:5n3; DHA, C22:6n3), the molecules are often reported to produce biochemical and physiological responses that are qualitatively and quantitatively different to each other.
Short term trials in humans have shown that EPA significantly reduces the levels of plasma triglycerides and may increase the levels of high density lipoproteins. The results of evaluations of EPA's use in patients with renal disorders, mild hypertension, inflammatory disorders or hyperlipidemia have been promising. In fact, JELIS a large scale clinical trial that investigated the effects of eicosapentaenoic acid (EPA) on coronary artery disease (CAD) shows as EPA is a promising treatment for prevention of major coronary events and especially non-fatal coronary events. It should be emphasized that EPA's potential antithrombotic and antiatherogenic effects probably operate independently from any effect on serum cholesterol levels.
On the other hand, recent analysis of the effect of Eicosapentaenoic acid (EPA) in clinical trials in depression indicates that the ratio of the constituent fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may determine the effectiveness of the supplements.